SCHEMBL16757359

SCHEMBL16757359

CC(C)(C)N(CCOCCOCCOCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 8/20 0.65
DRD3 P35462 5/20 0.65
KCNH2 Q12809 4/20 0.65
USP2 O75604 3/20 0.65
HRH2 P25021 2/20 0.65
HTR2A P28223 2/20 0.65
HTR2B P41595 2/20 0.65
TDP1 Q9NUW8 2/20 0.65
SLC6A2 P23975 2/20 0.65
SLC6A4 P31645 2/20 0.65
SLC6A3 Q01959 2/20 0.65
TEK Q02763 1/20 0.65
DRD2 P14416 3/20 0.64
OPRK1 P41145 2/20 0.64
CHRM2 P08172 2/20 0.64
ADRA2A P08913 2/20 0.64
ADRA1A P35348 2/20 0.64
ABCB11 O95342 1/20 0.64
ADRA2B P18089 1/20 0.64
ADRA2C P18825 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2058756 0.81 DRD3 (0.95) HRH1DRD3KCNH2USP2HRH2
Hydrochloric Acid SCHEMBL10930690 0.81 HRH1 (0.96) HRH1DRD3KCNH2USP2HRH2
Etodroxizine SCHEMBL9064076 0.80 DRD3 (0.98) HRH1DRD3KCNH2USP2HRH2
Etodroxizine SCHEMBL668191 0.80 DRD3 (0.98) HRH1DRD3KCNH2USP2HRH2
SCHEMBL13302855 0.80 DRD3 (0.76) HRH1DRD3KCNH2USP2HRH2
SCHEMBL2058384 0.80 HRH1 (0.80) HRH1DRD3KCNH2USP2HRH2
SCHEMBL13949317 0.79 DRD3 (0.83) HRH1DRD3KCNH2USP2HRH2
SCHEMBL10063666 0.79 DRD3 (0.83) HRH1DRD3KCNH2USP2HRH2
SCHEMBL13035055 0.79 DRD3 (0.83) HRH1DRD3KCNH2USP2HRH2
SCHEMBL18361270 0.79 DRD3 (0.63) HRH1DRD3KCNH2USP2HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3074001-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS AND CANCER The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) 2016-10-05 EP disclosed
WO-2015080949-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS AND CANCER THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2015-06-04 WO disclosed